Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
AmericaFirst Monthly Risk-On Risk-Off A ABRFX
- NAV / 1-Day Return 14.65 / +0.41 %
- Total Assets 5.1 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.870%
- Distribution Fee Level High
- Share Class Type Front Load
- Category Tactical Allocation
- Investment Style Mid Growth
- Credit Quality / Interest Rate Sensitivity —
- Status Open
- TTM Yield —
- Turnover 326%
USD | NAV as of Mar 27, 2024 | 1-Day Return as of Mar 27, 2024, 10:15 PM GMT+0
Morningstar’s Analysis ABRFX
Will ABRFX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 51.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Cash & Cash Equivalents | 13.22 | 676,889 | Cash and Equivalents |
Nu Holdings Ltd Ordinary Shares Class A | 8.05 | 411,866 | Financial Services |
TG Therapeutics Inc | 7.01 | 358,951 | Healthcare |
Gritstone Bio Inc | 6.00 | 307,000 | Healthcare |
Monte Rosa Therapeutics Inc | 5.41 | 276,716 | Healthcare |
Eli Lilly and Co | 5.12 | 262,281 | Healthcare |
Novo Nordisk A/S ADR | 4.68 | 239,540 | Healthcare |
Meta Platforms Inc Class A | 4.08 | 208,795 | Communication Services |
NVIDIA Corp | 3.86 | 197,780 | Technology |
DraftKings Inc Ordinary Shares - Class A | 3.85 | 196,889 | Consumer Cyclical |